Pulmatrix - 48 Year Dividend Yield History | PULM

Historical dividend payout and yield for Pulmatrix (PULM) since 1971. The current TTM dividend payout for Pulmatrix (PULM) as of March 21, 2019 is $0.00. The current dividend yield for Pulmatrix as of March 21, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.011B $0.000B
Pulmatrix, Inc. is a biopharmaceutical company which is engaged in developing inhaled therapies for serious pulmonary disease. The Company's proprietary product pipeline includes PUR1900, an inhaled anti-fungal for cystic fibrosis, PUR0200, a branded generic for chronic obstructive pulmonary disease which are in different clinical stage. Its technology platform consists of iSPERSE. Pulmatrix, Inc., formerly known as Ruthigen, Inc., is based in Lexington, MA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $119.409B 13.32
Gilead Sciences (GILD) United States $82.806B 10.54
Bio-Techne Corp (TECH) United States $7.570B 51.00